PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Cook General BioTechnology, LLC (CGBT)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Device Lessens Negative Effects of Stem Cell Transplants Says General BioTechnology Expert - Biotech company creates device that filters out harmful effects of cryoprotectant
Device Lessens Negative Effects of Stem Cell Transplants Says General BioTechnology Expert

 

NewswireToday - /newswire/ - Indianapolis, IN, United States, 2008/02/01 - Biotech company creates device that filters out harmful effects of cryoprotectant.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Stem cell transplants are used to treat patients whose bone marrow and other blood cells have been negatively affected by cancer and other diseases. Because stem cells immediately ready for transplant are nearly impossible to obtain, any patient seeking to undergo a stem cell transplant must use cells that have been frozen, or cryopreserved. Unfortunately, the best way to currently freeze stem cells involves using DMSO, a potentially toxic solution that aides in cryopreservation.

Typically, frozen-thawed stem cells are filtered into the body along with DMSO, because there is not an effective way to remove the DMSO without losing a significant amount of stem cells. Unfortunately, the effects of DMSO on a patient range from fever and nausea to violent cramping and even death. The biotech company General BioTechnology LLC in Indianapolis, Indiana has developed a machine that filters out the DMSO from thawed stem cells and therefore lessens the negative affect of the preservative on the patient.

Following chemotherapy treatments and radiation treatments, more and more cancer patients are seeking stem cell transplants as a method of recovery. If a patient’s bone marrow stops producing new blood cells, a stem cell transplant can destroy the dysfunctional marrow and will ideally regenerate growth of new blood cells. But since the cryopreservative DMSO’s side effects are just as bad as those from chemotherapy, many patients neglect considering the benefits of a stem cell transplant because the immediate risk is too great. General BioTechnology LLC (gnrlbiotech.com) believes its device can change all this. During Phase I research, General BioTechnology CEO Dr. Erik Woods developed a sophisticated cell washing process that results in a nearly complete recovery of unharmed stem cells.

Dr. Woods’ device has the potential to be operational in any hospital or health care facility. The device will be easy to use and ideally will arrive at a health care facility with everything a provider needs to use the machine. The dialysis process utilized by the device can also remove other, unwanted constituents from blood using the same dialysis process, so the usability of this machine extends beyond stem cell transplants and into mainstream health care.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cook General BioTechnology, LLC (CGBT)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Device Lessens Negative Effects of Stem Cell Transplants Says General BioTechnology Expert

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Erik Woods, Ph.D. - GnrlBioTech.com 
317-917-3450 x03 liz[.]gnrlbiotech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cook General BioTechnology, LLC (CGBT) securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cook General BioTechnology, LLC (CGBT) / Company Profile


Read Research Most Recent Related Newswires:

DSM-Niaga Ready for Commercial Scale Production of 100%-recyclable Carpets
DSM Dyneema Introduces Whole New Level of Cut Protection with Black Dyneema® Diamond Technology
DSM Presents Sustainable and Healthy Dairy Solutions At FoodTech 2016
Frost & Sullivan Highlights GENEWIZ's Commitment to Providing Cutting-edge Services in the Life Science Research Services Market
DSM to Present its Latest Advances in Skin Biochemistry At IFSCC Conference
DSM Launches ForTii® Ace Next Generation High Performance Polyamides
DSM Launches New Cultures to Reduce Cheese Ripening Time
DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category
DSM to Highlight its Health and Indulgence Solutions for Baked Goods At IBIE
DSM Welcomes EU Novel Foods Approval for Heart Health Antioxidant
DSM Dyneema Successfully Defends Key Patent Against Competitor Challenge
DSM Expands its Automotive Electronics Portfolio with High-flow Akulon PA66
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
BD Announces New Software Release for Pyxis Enterprise Solution
DSM Opens its Asia Pacific Personal Care Technical & Application Center in Shanghai

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)